First Glycopeptide-Resistant Enterococcus faecium Isolate from Blood Culture in Ankara, Turkey
Author Information
Author(s): Michael Dan, Francesca Poch, Daniel Shpitz, Bracha Sheinberg, Dhammika Nanda Atapattu, Dhammika Priyal Jayawickrama, Vasanthi Thevanesam
Primary Institution: University of Peradeniya, Peradeniya, Sri Lanka; General Hospital, Kandy, Sri Lanka
Conclusion
The first glycopeptide-resistant Enterococcus faecium isolate was identified in a patient with acute myelocytic leukemia in Ankara, Turkey.
Supporting Evidence
- The patient had fever episodes during neutropenia following chemotherapy.
- The strain was resistant to all antibiotics except ciprofloxacin and levofloxacin.
- VAN-A1 and Van-A2 type resistance genes were detected.
Takeaway
A patient in Turkey got a rare infection from a type of bacteria that doesn't respond to common antibiotics, which is a big concern in hospitals.
Methodology
The isolate was identified using conventional methods, commercial automatic systems, and polymerase chain reaction, with susceptibility patterns assessed using the E-test.
Limitations
The study is based on a single case, limiting the generalizability of the findings.
Participant Demographics
A 68-year-old man with acute myelocytic leukemia.
Want to read the original?
Access the complete publication on the publisher's website